Journal Information
Scientific Letter
Full text access
Pre-proof, online 21 November 2025
Impact of dosing on functional and clinical outcomes of patients with progressive pulmonary fibrosis treated with Nintedanib: data from a real-world, multicentric, Italian study
Visits
5
Jacopo Cefalo1,
Corresponding author
jacopo.cefalo@asst-santipaolocarlo.it

Corresponding author: Respiratory Unit, ASST Santi Paolo e Carlo. Via A. Di Rudinì n.8, 20142, Milan, Italy
, Francesco Varone2, Fabrizio Luppi3, Paolo Cameli4, Stefania Cerri5, Mariangela Valentina Puci6, Alessia Martini2, Giovanni Franco3, Umberto Zanini3, Tommaso Pianigiani4, Athina Patsoura5, Luca Richeldi2, Elena Bargagli4, Giovanni Sotgiu6, Michele Mondoni1,7
1 Respiratory Unit, ASST Santi Paolo e Carlo, Milan, Italy
2 Respiratory Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
3 Respiratory Unit, Fondazione IRCCS “San Gerardo dei Tintori”, Università degli Studi di Milano Bicocca, Monza, Italy
4 Respiratory Diseases Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy
5 Respiratory Disease Unit, University Hospital of Modena, Modena, Italy
6 Clinical Epidemiology and Medical Statistics Unit, Dept of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
7 Department of Health Sciences, Università degli Studi di Milano, Milan, Italy
This item has received
Archivos de Bronconeumología
Article options
Tools